|
 |
|
 |
Hedgepath LLC |
 |
Press Releases |
|
Click on the press release below to view it in its entirety |
| Receive press releases from Hedgepath LLC: By Email |
RSS Feeds: |
|
|
Lawsuit alleges self-dealing in Hedgepath Pharmaceuticals, Inc. by its controlling stockholder, an indirect subsidiary of Mayne Pharma Group Ltd. with estimated damages exceeding $800,000,000. - July 23, 2019
HedgePath LLC, founder of HedgePath Pharmaceuticals, Inc. (OTC: HPPI) Challenges the Fairness of the Commercial License for the BCCNS Indication Granted by HPPI to the Controlling, Majority Shareholder. - January 03, 2019
|
| Press Releases 1 - 2 of 2 |
Page: 1 |
| |
